Wien, 28 - Repository of the LBI-HTA - Ludwig Boltzmann Gesellschaft

AbbildungsverzeichnisAbbildung 2.4-1: Darstellung des Auswahlprozesses (PRISMA Flow Diagram) .......................................................... 17Abbildung 2.4-2: Darstellung des Auswahlprozesses (PRISMA Flow Diagram) .......................................................... 18TabellenverzeichnisTabelle 1.2-1: Übersicht der Hersteller von RFA-Generatoren und Elektroden........................................................... 11Tabelle 1.4-1: Preise von Radiofrequenz-Generatoren und Nadeln................................................................................. 14Tabelle 2.2-1: Inclusion criteria ............................................................................................................................................. 15Tabelle 4.1-1: Results from case series on radiofrequency ablation for the treatment of benign thyroidnodules....................................................................................................................................................... 21Tabelle 4.1-2: Results from case series on radiofrequency ablation for the treatment of thyroid cancer ................... 24Tabelle 4.1-3: Results from case series on radiofrequency ablation for the treatment of benign(aldosterone-producing) adenomas of the adrenal gland................................................................... 28Tabelle 4.1-4: Results from case studies on radiofrequency ablation for the treatment of metastases ofthe adrenal gland...................................................................................................................................... 29Tabelle 5-1: Evidence profile: efficacy and safety of radiofrequency ablation for benign thyroid nodules ............... 32Tabelle 5-2: Evidence profile: efficacy and safety of radiofrequency ablation for thyroid cancer............................... 33Tabelle 5-3: Evidence profile: efficacy and safety of radiofrequency ablation for benign (aldosteronproducing)adenomas of the adrenal gland .......................................................................................... 34Tabelle 5-4: Evidence profile: efficacy and safety of radiofrequency ablation for the treatment ofmetastases of the adrenal gland.............................................................................................................. 34Tabelle 7-1: Schema für Empfehlungen auf Basis der Evidenzlage................................................................................. 394 LBI-HTA | 2012